Description: <p><b>Magnesium</b> — Magnesium (Mg²⁺; Mg) is an essential divalent mineral cation and obligatory cofactor for hundreds of enzymatic reactions, particularly reactions involving Mg-ATP, nucleic-acid synthesis, ion transport, membrane excitability, and cellular energy metabolism. It is formally classified as an essential mineral/electrolyte rather than an anticancer drug. Dietary magnesium is supplied by leafy vegetables, nuts, seeds, legumes, and whole grains; supplements commonly use citrate, glycinate, chloride, oxide, and other magnesium salts. Magnesium is tightly homeostatically regulated, and its effects differ substantially between correction of deficiency, physiologic sufficiency, manipulation of intracellular Mg²⁺/TRPM7 signaling, and high local concentrations produced experimentally or by degradable magnesium biomaterials.</p>
<p><b>Primary mechanisms (ranked):</b></p>
<ol>
<li>Mg-ATP formation and enzymatic support — Mg²⁺ complexes with ATP and is required for kinase activity, glycolysis, oxidative phosphorylation, DNA/RNA synthesis, and numerous metabolic enzymes; this is physiologically essential but is not selectively anticancer and can also support tumor-cell metabolism.</li>
<li>TRPM7-mediated Mg²⁺ homeostasis and ion signaling — TRPM7 integrates Mg²⁺, Ca²⁺, Zn²⁺, kinase signaling, proliferation, migration, autophagy, and cell survival. TRPM7 is frequently dysregulated in cancer, but the direction of effect depends on tumor type and whether the channel is inhibited, activated, or exposed to altered intracellular Mg²⁺.</li>
<li>Ca²⁺ antagonism and membrane stabilization — adequate Mg²⁺ restrains excessive Ca²⁺ influx and Ca²⁺-dependent signaling and helps stabilize membrane potential and neuromuscular function.</li>
<li>DNA synthesis, DNA repair, and genomic stability — Mg²⁺ is required by DNA polymerases and other enzymes involved in nucleic-acid metabolism; deficiency can increase genomic instability, but restoring Mg²⁺ does not selectively damage cancer DNA.</li>
<li>Inflammatory and oxidative-stress regulation — magnesium deficiency promotes inflammatory signaling and oxidative stress; correction generally decreases inflammatory/oxidative stress rather than functioning as a tumor-selective ROS generator.</li>
<li>High-local or experimentally elevated intracellular Mg²⁺ effects — selected cancer models show increased ROS, ER stress, altered ATP metabolism, autophagy disruption, cell-cycle arrest, or apoptosis when Mg²⁺ homeostasis is strongly perturbed. These findings should not be extrapolated directly to ordinary dietary supplementation.</li>
<li>Colorectal cancer prevention biology — human randomized data indicate that magnesium supplementation can modify TRPM7-genotype-dependent gut microbial populations and vitamin-D-related biology associated experimentally with colorectal carcinogenesis, but clinical cancer prevention has not been established.</li>
</ol>
<p><b>Bioavailability / PK relevance:</b> Oral absorption is incomplete and homeostatically regulated; approximately 30–40% of dietary magnesium is typically absorbed. More soluble salts such as citrate, chloride, lactate, and aspartate generally show greater gastrointestinal absorption than poorly soluble magnesium oxide, although comparative studies are not completely uniform. Serum Mg²⁺ is tightly maintained at approximately 0.75–0.95 mmol/L and represents less than 1% of total-body magnesium, making serum concentration an imperfect measure of whole-body or intracellular magnesium status. Renal excretion is the principal regulator of systemic magnesium balance.</p>
<p><b>In-vitro vs systemic exposure relevance:</b> Many cancer experiments involving increased extracellular Mg²⁺, intracellular Mg²⁺ manipulation, TRPM7 pharmacology, or degradable magnesium materials do not represent the exposure produced by routine oral supplementation. Physiologic oral supplementation primarily corrects deficiency and produces relatively small changes in systemic Mg²⁺ because renal and intestinal homeostasis restrict large increases. Consequently, ROS induction, apoptosis, and tumor suppression observed under specialized experimental conditions should be labeled context-dependent rather than treated as general effects of oral magnesium.</p>
<p><b>Clinical evidence status:</b> Established clinical use is nutritional/electrolyte replacement and treatment or prevention of magnesium deficiency, including hypomagnesemia caused by platinum chemotherapy or EGFR-targeted therapy. Cancer evidence consists mainly of observational associations, mechanistic/preclinical studies, supportive-care trials, and emerging prevention-biomarker RCTs. Magnesium supplementation is not an established anticancer treatment, cytotoxic therapy, radiosensitizer, or chemosensitizer. Excess supplemental magnesium commonly causes gastrointestinal effects; clinically important hypermagnesemia is mainly a concern with very high exposure or impaired renal function.</p>
<br>
Mineral for normal bone structure. Found in nuts, legumes, fiber rich whole grains, low-fat dairy products, greens - spinach, swiss chard, collard greens.<br>
RDA. 51+ years male420 mg. Female 320 mg<br>
Pumpkin seeds (hulled, roasted): 1 oz = 150 mg of magnesium<br>
Peanuts (dry roasted): 1 oz = 49 mg of magnesium.<br>
Shredded wheat (plain, unfrosted): 1 cup = 56 mg of magnesium.<br>
Milk (nonfat): 1 cup = 24 to 27 mg of magnesium<br>
Yogurt (plain, low fat): 8 oz = 42 mg of magnesium.<br>
Dark chocolate (70%-85% cocoa): 1 oz = 64 milligrams of magnesium.<br>
Water saskatoon 19mg/L<br>
<br>
Magnesium acts as a natural calcium antagonist<br>
Magnesium deficiency contributes to an exaggerated response to immune stress and oxidative stress is the consequence of the inflammatory response.<br>
Simultaneously, magnesium ion deficiency, which antagonize calcium ions, increases intracellular calcium overload, activating numerous calcium-dependent kinases and proteins, such as nitric oxide synthase and calcium-dependent calcium-binding proteins, further augmenting ROS production.<br>
<br>
Magnesium (Mg) is an essential mineral that plays a crucial role in various cellular processes, including energy production, DNA synthesis, and cell signaling. <br>
-Mg deficiency has been linked to an increased risk of cancer.<br>
-May theoretically improve Ascorbic Acid (IV) efficacy.<br>
<br>
<h3>Magnesium Cancer-Relevant Mechanisms</h3>
<table border="1" cellpadding="4" cellspacing="0">
<tr>
<th>Rank</th>
<th>Pathway / Axis</th>
<th>Cancer Cells</th>
<th>Normal Cells</th>
<th>TSF</th>
<th>Primary Effect</th>
<th>Notes / Interpretation</th>
</tr>
<tr>
<td>1</td>
<td>Mg-ATP and cellular bioenergetics</td>
<td>↑ enzymatic and metabolic capacity when Mg²⁺ is sufficient</td>
<td>↑ ATP-dependent enzyme function</td>
<td>P–R</td>
<td>Essential metabolic cofactor</td>
<td>Most intracellular ATP exists functionally as Mg-ATP. Adequate Mg²⁺ is therefore not selectively anticancer and may support metabolism in both malignant and normal cells.</td>
</tr>
<tr>
<td>2</td>
<td>TRPM7 magnesium and ion homeostasis</td>
<td>↔ proliferation, migration and survival (context-dependent)</td>
<td>↑ Mg²⁺ homeostasis and ion regulation</td>
<td>P–G</td>
<td>Ion-channel and kinase regulation</td>
<td>TRPM7 conducts Mg²⁺ and other divalent cations and participates in proliferation and migration. Both TRPM7 inhibition and strong TRPM7 activation can suppress cancer phenotypes through different mechanisms, so a single up or down direction is inappropriate.</td>
</tr>
<tr>
<td>3</td>
<td>Calcium antagonism and signaling</td>
<td>↓ excessive Ca²⁺ signaling when Mg²⁺ deficiency is corrected</td>
<td>↓ Ca²⁺ overload</td>
<td>P</td>
<td>Membrane and signaling stabilization</td>
<td>Mg²⁺ acts physiologically as a Ca²⁺ antagonist and modulates channels, membrane excitability and Ca²⁺-dependent enzymes.</td>
</tr>
<tr>
<td>4</td>
<td>DNA synthesis and genomic stability</td>
<td>↑ DNA synthesis and repair capacity</td>
<td>↑ genomic stability</td>
<td>G</td>
<td>Nucleic-acid enzyme support</td>
<td>Mg²⁺ is required by polymerases and many enzymes involved in DNA and RNA metabolism. Correction of deficiency is protective rather than selectively genotoxic to malignant cells.</td>
</tr>
<tr>
<td>5</td>
<td>Inflammatory NF-κB signaling</td>
<td>↓ inflammatory signaling (deficiency correction)</td>
<td>↓ inflammatory signaling</td>
<td>R–G</td>
<td>Inflammatory normalization</td>
<td>Low magnesium promotes inflammatory physiology. Supplementation primarily normalizes this state rather than functioning as a tumor-selective NF-κB inhibitor.</td>
</tr>
<tr>
<td>6</td>
<td>Oxidative stress from magnesium deficiency</td>
<td>↓ ROS (deficiency correction)</td>
<td>↓ ROS and oxidative damage</td>
<td>R–G</td>
<td>Redox stabilization</td>
<td>The usual systemic effect of restoring Mg²⁺ deficiency is reduced oxidative stress. This direction differs from specialized experimental cancer models that intentionally perturb intracellular Mg²⁺ or TRPM7.</td>
</tr>
<tr>
<td>7</td>
<td>TRPM7 activation and autophagy disruption</td>
<td>↓ autophagic flux; ↑ ROS; ↑ apoptosis; ↓ proliferation (model-dependent)</td>
<td>↔ (model-dependent)</td>
<td>R–G</td>
<td>Experimental tumor suppression</td>
<td>Strong pharmacologic stimulation of TRPM7 has suppressed autophagy and increased ROS, apoptosis and cell-cycle arrest in cancer models. This is a TRPM7-targeting phenomenon rather than evidence that routine magnesium supplementation reproduces the effect.</td>
</tr>
<tr>
<td>8</td>
<td>Intracellular magnesium elevation and stress signaling</td>
<td>↑ ROS; ↑ ER stress; ↑ MAPK; ↑ apoptosis (context-dependent)</td>
<td>↔</td>
<td>R–G</td>
<td>Experimental stress response</td>
<td>In selected models, experimentally induced intracellular Mg²⁺ elevation accompanies ATP depletion, ROS generation and apoptosis. The effect depends strongly on the initiating treatment and cannot be generalized to oral Mg²⁺.</td>
</tr>
<tr>
<td>9</td>
<td>Extracellular magnesium and tumor growth</td>
<td>↑ or ↓ tumor growth (model-dependent)</td>
<td>↔</td>
<td>G</td>
<td>Biphasic cancer biology</td>
<td>Moderately elevated extracellular Mg²⁺ has increased proliferation, migration and xenograft growth in some models, demonstrating that magnesium is not intrinsically tumor suppressive.</td>
</tr>
<tr>
<td>10</td>
<td>Colorectal microbiome and vitamin D axis</td>
<td>↓ carcinogenic environment (indirect; genotype-dependent)</td>
<td>↑ selected microbiota and vitamin-D-associated biology</td>
<td>G</td>
<td>Potential cancer prevention mechanism</td>
<td>A human randomized trial found TRPM7-genotype-dependent changes in selected gut bacteria after magnesium treatment. Clinical reduction in colorectal cancer incidence has not yet been demonstrated.</td>
</tr>
<tr>
<td>11</td>
<td>Cancer therapy hypomagnesemia</td>
<td>↔ direct tumor effect</td>
<td>↑ magnesium status</td>
<td>G</td>
<td>Supportive oncology care</td>
<td>Platinum drugs and EGFR inhibitors can cause clinically important magnesium depletion. Replacement is supportive care and should not be interpreted as direct anticancer therapy.</td>
</tr>
<tr>
<td>12</td>
<td>Clinical Translation Constraint</td>
<td>↔ physiologic supplementation</td>
<td>↑ deficiency correction</td>
<td>G</td>
<td>Homeostatic exposure limitation</td>
<td>Renal regulation limits systemic Mg²⁺ elevation. Many anticancer findings require nonphysiologic extracellular concentrations, intracellular ion manipulation, TRPM7 pharmacology, or local magnesium biomaterials. Ordinary supplements have no established direct anticancer efficacy.</td>
</tr>
</table>
<div><b>TSF Legend:</b> P: 0–30 min R: 30 min–3 hr G: >3 hr</div>
<br>
<hr>
<br>
<p><b>Magnesium and Alzheimer’s disease:</b> Alzheimer’s-related evidence is strongest for magnesium L-threonate (MgT), a magnesium formulation developed to increase brain magnesium exposure. APP/PS1 mouse studies report improved cognition, synaptic preservation, reduced inflammatory and oxidative-stress signaling, and effects on amyloid-associated pathways. More recent work also implicates hippocampal neurogenesis and the microbiota-gut-brain axis. Human randomized trials of MgT have reported cognitive effects in healthy adults and older adults with cognitive impairment, but MgT has not been demonstrated to treat or modify established Alzheimer’s disease in a definitive AD clinical trial.</p>
<p><b>Clinical translation:</b> The AD entry should therefore be classified as substantial preclinical evidence with limited indirect human cognitive evidence rather than established Alzheimer’s therapy.</p>
<h3>Magnesium Alzheimer’s-Relevant Mechanisms</h3>
<table border="1" cellpadding="4" cellspacing="0">
<tr>
<th>Rank</th>
<th>Pathway / Axis</th>
<th>Modulation</th>
<th>Primary Effect</th>
<th>Notes / Interpretation</th>
</tr>
<tr>
<td>1</td>
<td>Synaptic plasticity and neuronal magnesium</td>
<td>↑</td>
<td>Synaptic preservation and cognitive support</td>
<td>Brain-magnesium elevation with MgT has improved synaptic function and cognition in experimental models. Formulation and brain exposure are important.</td>
</tr>
<tr>
<td>2</td>
<td>CREB and neuroplasticity signaling</td>
<td>↑</td>
<td>Learning and memory signaling</td>
<td>MgT-associated effects include restoration of neuroplasticity pathways and increased hippocampal neurogenesis in AD models.</td>
</tr>
<tr>
<td>3</td>
<td>Hippocampal neurogenesis</td>
<td>↑</td>
<td>Neuronal replacement and memory support</td>
<td>Recent APP/PS1 work reports attenuation of impaired adult hippocampal neurogenesis through ERK and CREB-associated mechanisms.</td>
</tr>
<tr>
<td>4</td>
<td>Neuroinflammation</td>
<td>↓</td>
<td>Reduced inflammatory injury</td>
<td>MgT has reduced inflammatory signaling in AD models; this remains predominantly preclinical evidence.</td>
</tr>
<tr>
<td>5</td>
<td>Oxidative stress</td>
<td>↓</td>
<td>Neuroprotection</td>
<td>Reduction of oxidative stress has been reported in experimental MgT studies.</td>
</tr>
<tr>
<td>6</td>
<td>Amyloid pathology</td>
<td>↓</td>
<td>Reduced amyloid-associated pathology</td>
<td>Effects on Aβ-related pathology have been demonstrated in transgenic mouse models but not established as disease modification in humans.</td>
</tr>
<tr>
<td>7</td>
<td>Microbiota gut brain axis</td>
<td>↑ beneficial modulation</td>
<td>Barrier and metabolic support</td>
<td>MgT modified gut microbial composition, serum metabolites and intestinal-barrier proteins in APP/PS1 mice.</td>
</tr>
<tr>
<td>8</td>
<td>Clinical Translation Constraint</td>
<td>↔</td>
<td>Human evidence limitation</td>
<td>Human MgT studies provide cognitive signals but do not establish prevention or treatment of Alzheimer’s disease. Evidence for ordinary magnesium salts cannot automatically be extrapolated from MgT studies.</td>
</tr>
</table>